[1] |
SIMON DI.Inflammation and vascular injury: basic discovery to drug development[J]. Circ J, 2012, 76(8):1811-1818.
|
[2] |
NARUKO T, UEDA M, EHARA S,et al.Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis[J]. Arterioscler Thromb Vasc Biol,2006,26(4): 877-883.
|
[3] |
LAN Z, LYU Y, XIAO J, et al.Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease[J]. J Biomed Nanotechnol, 2014, 10(7):1194-1204.
|
[4] |
KASTRATI A,MEHILLI J,VON BECKERATH N,et al.Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial[J]. JAMA,2005,293(2):165-171.
|
[5] |
CÔTÉ N,PIBAROT P,PÉPIN A,et al. Oxidized low-density lipoprotein,angiotensin Ⅱ and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis[J]. Int J Cardiol,2010,145(3):444-449.
|
[6] |
陈帅,贺能树. 血管支架内再狭窄的研究进展[J]. 国际医学放射学杂志,2011,34(4): 349-352.
|
[7] |
MULLER O,NTALIANIS A,WIJNS W,et al.Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease[J]. J Cardiovasc Transl Res,2013,6(4):536-544.
|
[8] |
葛庆峰,闫杰,白华. 血清氧化型低密度脂蛋白自身抗体水平与冠状动脉病变程度的关系[J]. 陕西医学杂志,2005,34(8): 944-946.
|
[9] |
KARACA I,AYDIN K,YAVUZKIR M,et al.Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation[J]. J Int Med Res,2005,33(4):389-396.
|
[10] |
马燚,闫华,姜玉凤. C-反应蛋白与冠状动脉支架置入术后再狭窄的关系[J]. 中国煤炭工业医学杂志,2005,8(8): 868-869.
|
[11] |
LI B,ZHANG LH,YANG XG,et al.Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease[J]. Coron Artery Dis,2011,22(4):259-263.
|
[12] |
NARUKO T,UEDA M,EHARA S,et al.Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis[J]. Arterioscler Thromb Vasc Biol,2006,26(4):877-883.
|
[13] |
CHAABANE C, OTSUKA F, VIRMANI R, et al.Biological responses in stented arteries[J]. Cardiovasc Res, 2013, 99(2):353-363.
|
[14] |
TSIMIKAS S,LAU HK,HAN KR,et al.Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein[J]. Circulation,2004,109(25):3164-3170.
|
[15] |
YAO EH,FUKUDA N,UENO T,et al.Novel gene silencer pyrrole-imidazole polyamide targeting lectin-like oxidized low-density lipoprotein receptor-1 attenuates restenosis of the artery after injury[J]. Hypertension,2008,52(1):86-92.
|
[16] |
ROGHANI F, MEHRABI KOUSHKI A, NEZARAT N, et al.The correlation between early complications of percutaneous coronary intervention and high sensitive C-reactive protein[J]. ARYA Atheroscler, 2013, 9(4):263-267.
|